Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 732.10
-0.05 (-0.01%)
May 22, 2026, 3:29 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 14.69 billion as of May 22, 2026. Its market cap has increased by 29.94% in one year.
Market Cap
14.69B
Enterprise Value
12.37B
Revenue
6.52B
Ranking
n/a
PE Ratio
16.72
Stock Price
732.10
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 14.69B, an increase of 10,475.45%. That is a compound annual growth rate of 24.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 14.69B | 51.78% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 48.54B |
| RPG Life Sciences | 37.61B |
| Orchid Pharma | 35.89B |
| Solara Active Pharma Sciences | 27.18B |
| Indoco Remedies | 18.86B |
| Sakar Healthcare | 17.51B |
| Windlas Biotech | 16.51B |
| Jagsonpal Pharmaceuticals | 14.22B |